Recombinant LH in ovarian stimulation (Q34428080)

2 August 2017

1 reference

title

Recombinant LH in ovarian stimulation (English)

1 reference

2 August 2017

Gamze Sinem Caglar

1

1 reference

2 August 2017

Byron Asimakopoulos

2

1 reference

2 August 2017

Nikos Nikolettos

3

1 reference

2 August 2017

Klaus Diedrich

4

1 reference

2 August 2017

Safaa Al-Hasani

5

1 reference

2 August 2017

publication date

1 June 2005

1 reference

Reproductive BioMedicine Online

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

774-785

1 reference

Pregnancy after treatment with three recombinant gonadotropins

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

1 reference

7 January 2021

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The role of luteinizing hormone in human follicular maturation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Studies on the disappearance of LH and FSH in the rat; a quantitative approach to adenohypophysial secretory kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human menopausal gonadotrophin (HMG). 3. Effects of a biologically apparently pure FSH preparation on ovaries and uteri of intact, immature mice

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The role of luteinizing hormone in folliculogenesis and ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Use of luteinizing hormone in the treatment of infertility: time for reassessment?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Stimulation and growth of antral ovarian follicles by selective LH activity administration in women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

What clinical evidence for an LH ceiling?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Treatment and causes of female infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Use of recombinant LH in a group of unselected IVF patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Evidence for a Role of Androgens in Follicular Maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Polycystic ovaries and recurrent miscarriage--a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recurrent early miscarriage and polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Direct ovarian effects and safety aspects of GnRH agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Luteinizing hormone affects uterine receptivity independently of ovarian function

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Gonadotropin requirements of the developing follicle.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Gonadotropins and gonadotropin receptors during the perimenopause.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961123-6

7 January 2021

Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000410

Identifiers

DOI

10.1016/S1472-6483(10)61123-6

1 reference

2 August 2017

1 reference